Select for export “A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0279073 PubMed 36516137 Copy citation Copy BibTeX PLoS ONE 2022-12-13 Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley OpenAlex Published psilocybin DepressionAddictionEmotional Processing Clinical Trial More
Select for export Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221131997 PubMed 36515370 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-12-13 Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Psychedelic Identity Shift: A Critical Approach to Set And Setting Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1353/ken.2022.0022 PubMed 38588216 Copy citation Copy BibTeX Kennedy Institute of Ethics journal 2022-11-30 Neşe Devenot, Aidan Seale-Feldman, Elyse Smith, Tehseen Noorani, Albert Garcia-Romeu, Matthew W. Johnson OpenAlex Published psilocybin AddictionMechanism of Action Other More
Select for export Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.31796 PubMed 36569662 Copy citation Copy BibTeX Unknown journal 2022-11-21 Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-11-07 NYU Langone Health ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Other More
Select for export Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s13205-022-03355-4 PubMed 36340802 Copy citation Copy BibTeX Unknown journal 2022-11-03 Strauss D, Ghosh S, Murray Z, Gryzenhout M. Europe PMC Published psilocybinpsilocin Receptor PharmacologyReview Article Review Article More
Select for export Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.cct.2022.106976 PubMed 36332827 Copy citation Copy BibTeX Contemporary Clinical Trials 2022-11-01 O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J Europe PMC Published psilocybin AddictionReceptor PharmacologyRandomized Controlled Trial Randomized Controlled Trial More
Select for export The psychedelic renaissance: can psilocybin possibly combat depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/gh9.0000000000000089 Copy citation Copy BibTeX International Journal of Surgery Global Health 2022-10-31 Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh OpenAlex Published psilocybin DepressionAnxietyPTSD Systematic Review More
Select for export Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.10.31.22281688 Copy citation Copy BibTeX medRxiv 2022-10-31 Mason N, Szabo A, Kuypers K, Mallaroni P, de la Torre Fornell R, Reckweg J medRxiv PREPRINT (not peer reviewed) psilocybin DepressionMechanism of ActionBiomarkers Other More
Select for export A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2022.0002 PubMed 37337526 Copy citation Copy BibTeX Psychedelic Medicine 2022-10-27 Nayak SM, Bari BA, Yaden DB, Spriggs MJ, Rosas FE, Peill JM Europe PMC Published psilocybin Depression Other More
Select for export Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX PsyArXiv 2022-10-18 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin MicrodosingWellbeingCreativity Other More
Select for export Animal Behavior in Psychedelic Research. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1124/pharmrev.122.000590 PubMed 36180111 Copy citation Copy BibTeX Unknown journal 2022-09-30 Odland AU, Kristensen JL, Andreasen JT. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Review Article More
Select for export The use of classic psychedelics among adults: a Danish online survey study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/08039488.2022.2125069 PubMed 36173202 Copy citation Copy BibTeX Nordic Journal of Psychiatry 2022-09-28 Søgaard Juul T, Ebbesen Jensen M, Fink-Jensen A. Europe PMC Published psilocybin WellbeingSpiritualityMystical Experience Observational Study More
Select for export Psilocybin as a healer Abstract available at the source but not redistributed here. Read at source. Details DOI 10.53074/cstp.2022.37 Copy citation Copy BibTeX Consciousness Spirituality & Transpersonal Psychology 2022-09-11 Kavita Golia OpenAlex Published psilocybin DepressionMicrodosingWellbeing Other More
Select for export Long-term transformative effects and integration challenges of psychedelic experiences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.53074/cstp.2022.29 Copy citation Copy BibTeX Consciousness Spirituality & Transpersonal Psychology 2022-09-11 Victor Jivanescu OpenAlex Published psilocybin Emotional ProcessingSpiritualityObservational Study Observational Study More
Select for export A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s40263-022-00944-y PubMed 36097251 Copy citation Copy BibTeX Unknown journal 2022-09-11 Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM Europe PMC Published psilocybin Randomized Controlled TrialSystematic ReviewReview Article Randomized Controlled Trial More
Select for export Neural mechanisms of psychedelic visual imagery Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.09.07.22279700 Copy citation Copy BibTeX medRxiv 2022-09-08 Stoliker D, Preller KH, Novelli L, Anticevic A, Egan GF, Vollenweider FX medRxiv PREPRINT (not peer reviewed) psilocybin NeuroplasticityMechanism of ActionReceptor Pharmacology Animal Study More
Select for export Effective connectivity of emotion and cognition under psilocybin Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.09.06.22279626 Copy citation Copy BibTeX medRxiv 2022-09-08 Stoliker D, Novelli L, Vollenweider FX, Egan GF, Preller KH, Razi A. medRxiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionDefault Mode Network Clinical Trial More
Select for export Microdosing psilocybin for chronic pain: a case series. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/j.pain.0000000000002778 PubMed 36066961 Copy citation Copy BibTeX Pain 2022-09-04 Lyes M, Yang KH, Castellanos J, Furnish T. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00221678221110331 Copy citation Copy BibTeX Journal of Humanistic Psychology 2022-08-17 Mark Molumby, Keith Gaynor, Suzanne Guérin, Róisín McNamara OpenAlex Published psilocybin Receptor PharmacologyPersonality Change Other More
